HCW Biologics Inc. / Fundamentals
Income statement
- Net revenue
€718.40K - Cost of goods sold
€574.72K - Gross profit
€143.68K - SG&A expenses
€7.14M - R&D expenses
€4.18M - EBITDA
-€9.85M - D&A
€699.52K - EBIT
-€10.59M - Interest expenses
€383.30K - EBT
-€18.59M - Tax expenses
€0.00 - Net income
-€18.59M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€1.17M - Changes in working capital
€115.39K - Operating cash flow
-€10.83M - Capex
€129.80K - Other investing cash flow
€0.00 - Net investing cash flow
-€129.80K - Total cash dividends paid
€0.00 - Issuance of common stock
€3.98M - Debt repayment
€2.92M - Other financing cash flow
€5.27M - Net financing cash flow
€12.06M - Foreign exchange effects
€0.00 - Net change in cash
€1.10M - Cash at end of period
€2.10M - Free cash flow
-€10.70M
Balance sheet
- Cash and cash equivalents
€2.10M - Cash and short-term investments
€2.10M - Total receivables
€18.64K - Inventory
€0.00 - Other current assets
€376.57K - Total current assets
€2.50M - Property, plant & equipment
€19.53M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€2.89M - Other non-current assets
€24.56K - Total non-current assets
€22.44M - Total assets
€24.94M - Accounts payable
€16.69M - Short-term debt
€5.54M - Other current liabilities
€923.33K - Total current liabilities
€23.16M - Long-term debt
€316.70K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€1.82M - Total non-current liabilities
€1.82M - Total liabilities
€24.98M - Common stock
€185.46 - Retained earnings
-€90.30M - Other equity
€0.00 - Total equity
-€44.83K - Total liabilities and shareholders' equity
€24.94M
Company information
- Market capitalization
€9.26M - Employees
36 - Enterprise Value
€17.73M
Company ratios
- Gross margin
-
20.0% Much better than peer group: -395.5% - EBITDA margin
-
-1,371.6% Much better than peer group: -3,476.9% - EBIT margin
-
-1,474.5% Much better than peer group: -9,651.3% - EBT margin
-
-2,588.0% Much better than peer group: -307,780.2% - Net margin
-
-2,588.0% Much better than peer group: -3,534.0% - ROE
-
41,472.3% Much better than peer group: -303.8% - ROA
-
-74.6% Much better than peer group: -321.4% - Asset turnover
-
2.9% Much worse than peer group: 137.3% - FCF margin
-
-1,525.9% Much better than peer group: -21,139.2% - FCF yield
-118.3% - Efficiency ratio
1,471.6% - Net sales per employee
-
€19.96K - Net income per employee
-
-€516.45K